Viewing Study NCT06396221



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06396221
Status: RECRUITING
Last Update Posted: 2024-05-02
First Post: 2024-04-25

Brief Title: Quick-starting of a New Combined Hormonal Contraceptive Pills 15 mg Estetrol3 mg Drospirenone VS 20 mcg Ethinylestradiol75 mcg Gestodene Focusing on Ovulation Inhibition
Sponsor: Chulalongkorn University
Organization: Chulalongkorn University

Study Overview

Official Title: Quick-starting of a New Combined Hormonal Contraceptive Pills 15 mg Estetrol3 mg Drospirenone VS 20 mcg Ethinylestradiol75 mcg Gestodene Focusing on Ovulation Inhibition A Single-blind Randomized Controlled Non-inferiority Trial
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if EstetrolDrospirenone inhibit ovulation in quick-starting method It will also learn about the safety of EstetrolDrospirenone The main questions it aims to answer are

1 Does EstetrolDrospirenone inhibit ovulation inferior to Ethinyl estradiolGestodene when starting on Day 7-9 of menstrual cycle
2 What are the impacts of EstetrolDrospirenone on ovarian activities when starting on Day 7-9 of menstrual cycle
3 How does the cervical mucus change when starting EstetrolDrospirenone on Day 7-9 of menstrual cycle
4 What are the adverse effects when starting EstetrolDrospirenone on Day 7-9 of menstrual cycle

Researchers will compare EstetrolDrospirenone to Ethinyl estradiolGestodene to see if EstetrolDrospirenone inhibit ovulation in quick-starting method
Detailed Description: Participants will

Take EstetrolDrospirenone or Ethinyl estradiolGestodene starting on day 7-9 of menstrual cycle then every day for 1 pack of the pills

Visit the clinic on day 1-2 day 7-9 and then every 2-7 days according to ultrasound finding ovarian activities until completing of pills to investigate

1 Transvaginal ultrasound
2 Cervical mucus
3 Serum hormonal profiles

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None